Precise DNA genotyping diagnosis of hydatidiform mole

Obstetrics and Gynecology

Volumn 115, Issue 4, 2010, Pages 784-794

  Lipata, Fredilyn ^a   Parkash, Vinita ^a   Talmor, Monica ^a   Bell, Susan ^a   Chen, Suping ^a   Maric, Vesna ^a   Hui, Pei ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHROMOSOME ABERRATION; CONCEPTION; DISEASE CLASSIFICATION; DNA GENOTYPE; FEMALE; GENE LOCUS; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN GENOME; HUMAN TISSUE; HYDATIDIFORM MOLE; KLINEFELTER SYNDROME; MAJOR CLINICAL STUDY; MONOSOMY; MULTIPLEX POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; TRIPLOIDY; TRISOMY; TRISOMY 13; TRISOMY 16; TRISOMY 18; TRISOMY 21; TRISOMY 4; TRISOMY 7; TRISOMY 8;

CHROMOSOME DISORDERS; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; HYDATIDIFORM MOLE; POLYMERASE CHAIN REACTION; PREGNANCY; TANDEM REPEAT SEQUENCES; UTERINE NEOPLASMS;

EID: 77949888512     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181d489ec     Document Type: Article

References (26)

1. Genest D. Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis. Int J Gynecol Pathol 2001;20: 315-322
2. Berkowitz RS, Goldstein DP. Molar pregnancy. N Engl J Med 2009;360:1639-1645
3. Hui P, Martel M, Parkash V. Gestational trophoblastic diseases: recent advances in histopathologic diagnosis and related genetic aspects. Adv Anat Pathol 2005;12:116-125
4. Fukunaga M, Katabuchi H, Nagasaka T, Mikami Y, Minamiguchi S, Lage JM. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol 2005;29:942-947
5. Howat AJ, Beck S, Fox H, Harris SC, Hill AS, Nicholson CM, et al. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol 1993;46:599-602.
6. Bifulco C, Johnson C, Hao LM, Kermalli H, Bell S, Hui P. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol 2008;32: 445-451
7. Kajii T, Ohama K. Androgenetic origin of hydatidiform mole. Nature 1977;268:633-634
8. Li HW, Tsao SW, Cheung AN. Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta 2002;23:20-31.
9. Sebire NJ, Rees HC, Peston D, Seckl MJ, Newlands ES, Fisher RA. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumors does not identify the type of the causative pregnancy. Histopathology 2004;45:135-141
10. Deveault C, Qian JH, Chebaro W, Ao A, Gilbert L, Mehio A, et al. NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation. Hum Mol Genet 2009;18:888-897
11. Kou YC, Shao L, Peng HH, Rosetta R, del Gaudio D, Wagner AF, et al. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles. Mol Hum Reprod 2008;14: 33-40.
12. Hayward BE, De Vos M, Talati N, Abdollahi MR, Taylor GR, Meyerer E, et al. Genetic and epigenetic analysis of recurrent hydatidiform mole. Hum Mutat 2009;30:E629-39.
13. Collins PJ, Hennessy LK, Leibelt C, Roby RK, Reeder DJ, Foxall PA. Developmental validation of a single-tube amplification of the 13 CODIS STR loci, D2S1338, D19S433, and amelogenin: the AmpFlSTR Identifiler PCR Amplification Kit. J Forensic Sci 2004;49:1265-1277
14. Bell KA, Van Deerlin V, Addya K, Clevenger CV, Van Deerlin PG, Leonard DG. Molecular genetic testing from paraffin-embedded tissue distinguishes nonmolar hydropic abortion from hydatidiform mole. Mol Diagn 1999;4:11-19
15. Nollet F, Billiet J, Selleslag D, Criel A. Standardization of multiplex fluorescent short tandem repeat analysis for chimer-ism testing. Bone Marrow Transplant 2001;28:511-518
16. Seckl MJ, Fisher RA, Salerno G, Rees H, Paradinas FJ, Foskett M, et al. Choriocarcinoma and partial hydatidiform moles. Lancet 2000;356:36-39
17. Zaragoza MV, Keep D, Genest DR, Hassold T, Redline RW. Early complete hydatidiform moles contain inner cell mass derivatives. Am J Med Genet 1997;70:273-277
18. Frierson HF. Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalin-fixed paraffin embedded specimens. Hum Pathol 1988;19:290-294.
19. Chilosi M, Piazzola E, Lestani M, Benedetti A, Guasparri I, Granchelli G, et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 1998;78:269-276
20. Fisher RA, Hodges MD, Rees HC, Sebire NJ, Seckl MJ, Newlands ES, et al. The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both andro-genetic and biparental complete hydatidiform moles. Hum Mol Genet 2002;11:3267-3272
21. McConnell TG, Murphy KM, Hafez M, Vang R, Ronnett BM. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol 2009;33:805-817
22. Helwani MN, Seoud M, Zahed L, Zaatari G, Khalil A, Slim R. A familial case of recurrent hydatidiform molar pregnancies with biparental molar contribution. Hum Genet 1999;105: 112-115
23. Hodges MD, Rees HC, Seckl MJ, Newlands ES, Fisher RA. Genetic refinement and physical mapping of a biparental complete hydatidiform mole locus on chromosome 19q13.4. J Med Genet 2003;40:e95.
24. Seki T, Fujita H, Okubo H, Shiina Y, Wake N, Ichinoe K, et al. The propensity to malignant changes in heterozygous moles. Nippon Sanka Fujinka Gakkai Zasshi 1982;34:2221-2228
25. Wake N, Fujino T, Hoshi S, Shinkai N, Sakai K, Kato H, et al. The propensity to malignancy of dispermic heterozygous moles. Placenta 1987;8:319-326
26. Klein ME, Pfeifer JD, Zehnbauer BA, Stephens AL, Huettner PC. Clinical significance of distinguishing homozygous from heterozygous complete hydatidiform mole. Mod Pathol 2009;22:221A.